Patent · US Active

Processes for the production of chemically-modified heparins

US10023659B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

DILAFOR AB · SE

Inventors

Per-Olov Eriksson · Hagfors, SE
Erik Holmer · Stockholm, SE

Key dates

Filing date	Jun 19, 2014
Grant date	Jul 17, 2018
Priority date	—
Expiry date	Sep 10, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a process for the production of heparin derivatives having an average molecular weight of from about 4.6 to about 6.9 kDa and an anti-factor Xa activity of less than about 10 IU/mg, comprising the steps of oxidation of unfractionated heparin, depolymerisation and reduction of resulting terminal groups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.